Your world leading CDMO. Targeted Therapies.

Targeted or precision therapies are a class of drugs developed to precisely interact with specific molecular targets that are involved in the growth, progression, and spread of diseases – particularly cancer.

Unlike traditional chemotherapies, which affect all rapidly dividing cells, targeted therapies aim to interfere with specific biological pathways or markers that are unique to diseased cells. This allows for greater precision in treatment, often leading to improved efficacy and reduced side effects.

Targeted therapy development requires detailed molecular understanding of disease pathways and often relies on biomarker identification to match the right drug with the right patient – a cornerstone of precision medicine.

These therapies can work by:

• Blocking the signals that tell cancer cells to grow.
• Inducing cancer cell death.
• Preventing the formation of new blood vessels that supply tumors.
• Delivering toxic agents directly to cancer cells (e.g., antibody-drug conjugates).

Analytical Capabilities for Development and Manufacturing

As a global leader of development and manufacturing services, a dedicated team will support your product lifecycle with method development, method optimization, method transfer and method qualification/validation.

Our dedicated team of specialists will be happy to discuss any of your Antibody-Drug Conjugate Product needs. Contact us on +1 215-613-3600 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com